drugset / Trial / NCT01279512

Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)

NCT01279512

Phase 4 Completed 50 enrolled Royan Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a prospective randomized clinical trial to compare the endocrine and metabolic effects of two anti diabetic drugs (metformin vs. acarbose) in infertile overweight women with PCOS

Timeline

Start
2006-12
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acarbose Unknown 300 mg
Subject Metformin Small molecule 1500 mg

Indications

No indication recorded.